Please Wait

Applying Filters...

Gyno-Terazol
USDMF
Table View

How Trump’s tariffs on imported drugs can hurt supply chains, consumers and industry

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Gyno-Terazol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 6 USDMF, 2 CEP/COS, 1 EU WC, 3 NDC API, 5 Listed Suppliers, $ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 10 FDA Orange Book, 1 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

3 Nanjing Well Pharmaceutical, 2 Actylis, 8 BASF, 1 Finar, 4 Gangwal Chemicals, 1 Nanjing Bold Chemical, 7 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

16 Solubilizers, 12 Topical, 6 Emulsifying Agents, 6 Parenteral, 5 Thickeners and Stabilizers, 4 Film Formers & Plasticizers, 4 Surfactant & Foaming Agents, 2 Direct Compression, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Lubricants & Glidants, 1 Granulation, 1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

1 Data Compilation #PharmaFlow

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Regulatory FDF Prices

MARKET PLACE

6 APIs

6 APIs

REF. STANDARDS & IMPURITIES

2 EDQM, 3 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	APOTECNIA SA	France	APOTECNIA SA	15680	TERCONAZOLE	2001-10-22	Inactive	II	N/A
28/03/2025	Derivados Quimicos SAU	Spain	DERIVADOS QUIMICOS SAU	20735	TERCONAZOLE	2007-07-30	Active	II	N/A

Contact us
to update this info

Gyno-Terazol

Gyno-Terazol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

6 USDMF

2 CEP/COS

1 EU WC

3 NDC API

5 Listed Suppliers

$ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers

10 FDA Orange Book

1 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

3 Nanjing Well Pharmaceutical

2 Actylis

8 BASF

1 Finar

4 Gangwal Chemicals

1 Nanjing Bold Chemical

7 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

16 Solubilizers

12 Topical

6 Emulsifying Agents

6 Parenteral

5 Thickeners and Stabilizers

4 Film Formers & Plasticizers

4 Surfactant & Foaming Agents

2 Direct Compression

1 Rheology Modifiers

1 API Stability Enhancers

1 Lubricants & Glidants

1 Granulation

1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 Regulatory FDF Prices

MARKET PLACE

6 APIs

REF. STANDARDS & IMPURITIES

2 EDQM

3 Others

Filters

CREAM;VAGINAL - 0.4% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SUPPOSITORY;VAGINAL - 80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;VAGINAL - 0.8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons